TABLE I.
Target | Aspect ratio | Geometric size(contraction/expansion width × length × height) | Note | Recovery | Reference |
---|---|---|---|---|---|
15/7 μm particles | ∼1 | 45 ∼ 50/200 × 100/200 × 50 ∼ 55 μm | Lower purity | 75.2%/93.7% | 58 |
15 μm particle | 1 | 40/200 × 100/200 × 40 μm | Two stage MOFF | 88.7% | 59 |
MCF-7 cells | 1 | 60/300 × 150/300 × 60 μm | Two stage MOFF | 98.9% | 22 |
MCF-7 cells/ MDA-MB-231 cells | 1 | 60/300 × 150/300 × 60 μm | Four MOFF in parallel | 93.75%/91.60% | 60 |
CTCs | 5 | 20/60 × 100/100 × 100 μm | With rare cell pinching region | 85% | 61 |
Malaria parasites/WBCs | … | 30/90 × −/− × − μm | … | 70.9 ± 11.4%/99.99% | 62 |
5.5/9.9 μm particles WBCs/RBCs | ∼2 | 45/120 × 45/500 × 21 μm | Long expansion channel | >92%/>98% 89.7%/99.8% | 63 |
CTCs | 1 | 60/300 × 150/300 × 60 μm | … | >80% | 67 |
NCI-H1299 cells | 2 | 100/400 × 200/400 × 50 μm | The shape of the cavity is a circle | >95% | 64 |